Literature DB >> 24626384

Semilobar holoprosencephaly with 21q22 deletion: an autopsy report.

Saumyaranjan Mallick1, Shasanka Shekhar Panda, Ruma Ray, Rashmi Shukla, Madhulika Kabra, Ramesh Agarwal.   

Abstract

Holoprosencephaly (HPE) is the most common forebrain developmental anomaly with a prevalence of 1:16 000 live-births. Possible aetiological agents include environmental factors and genetic defects such as trisomies (13, 18) and deletions (18p, 7q, 2p and 21q). This complex malformation is due to incomplete division of the cerebral hemisphere. The phenotypes of HPE include alobar, semilobar, lobar and midline interhemispheric fusion variants. Craniofacial anomalies occur in 80% of cases. Severely affected babies die in the neonatal period. Here we report an autopsied case of semilobar HPE with pituitary and adrenal agenesis with 21q22 deletion. Additional findings are noted that would help expand the spectrum of 21q22 deletion.

Entities:  

Mesh:

Year:  2014        PMID: 24626384      PMCID: PMC3962924          DOI: 10.1136/bcr-2014-203597

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Clinical and cytogenetic aspects of the 21 deletion syndrome.

Authors:  G S Gericke; M F Steyn; A E Retief; J C Thom; W A Van Niekerk
Journal:  S Afr Med J       Date:  1975-06-07

2.  Risk factors for nonsyndromic holoprosencephaly: a Manitoba case-control study.

Authors:  Simone S Vaz; Bernard Chodirker; Chitra Prasad; Jamie A Seabrook; Albert E Chudley; Asuri N Prasad
Journal:  Am J Med Genet A       Date:  2012-03-14       Impact factor: 2.802

3.  Risk factors for cytogenetically normal holoprosencephaly in California: a population-based case-control study.

Authors:  L A Croen; G M Shaw; E J Lammer
Journal:  Am J Med Genet       Date:  2000-02-14

4.  Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984-1989.

Authors:  C L Olsen; J P Hughes; L G Youngblood; M Sharpe-Stimac
Journal:  Am J Med Genet       Date:  1997-12-12

5.  Holoprosencephaly: epidemiologic and clinical characteristics of a California population.

Authors:  L A Croen; G M Shaw; E J Lammer
Journal:  Am J Med Genet       Date:  1996-08-23

6.  Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?

Authors:  R L Kelley; E Roessler; R C Hennekam; G L Feldman; K Kosaki; M C Jones; J C Palumbos; M Muenke
Journal:  Am J Med Genet       Date:  1996-12-30

7.  Velo-cardio-facial syndrome presenting as holoprosencephaly.

Authors:  J E Wraith; M Super; G H Watson; M Phillips
Journal:  Clin Genet       Date:  1985-04       Impact factor: 4.438

8.  Holoprosencephaly in an infant with a minute deletion of chromosome 21(q22.3).

Authors:  L L Estabrooks; K W Rao; R P Donahue; A S Aylsworth
Journal:  Am J Med Genet       Date:  1990-07

9.  Holoprosencephaly in infants of diabetic mothers.

Authors:  M Barr; J W Hanson; K Currey; S Sharp; H Toriello; R D Schmickel; G N Wilson
Journal:  J Pediatr       Date:  1983-04       Impact factor: 4.406

10.  Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly--a new syndrome? Part I: clinical, causal, and pathogenetic considerations.

Authors:  J G Hall; P D Pallister; S K Clarren; J B Beckwith; F W Wiglesworth; F C Fraser; S Cho; P J Benke; S D Reed
Journal:  Am J Med Genet       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.